Prismforce, a leading AI-powered talent supply chain company, today announced the global availability of SelectPrism, an ...
The near-term outlook for ClearPoint's biopharma business is also now clouded by FDA uncertainty around uniQure's AMT-130.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback